Position in RCKT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$7,368,724
-$3,116,684 QoQ
Shares Held
2,058,303
-31.1% QoQ
Ownership
1.89%
of shares outstanding
% of Portfolio
2.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Monaco Asset Management SAM holds $38,256,689 across 13 Biotechnology names. RCKT ranks #2 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
3,421,020 | $9,681,486 | |
| 2 | RCKT |
Rocket Pharmaceuticals, Inc.
This page
|
2,058,303 | $7,368,724 | |
| 3 | NVAX |
Novavax Inc
|
697,600 | $5,678,464 | |
| 4 | NKTX |
Nkarta, Inc.
|
2,521,932 | $5,321,276 | |
| 5 | PLRX |
Pliant Therapeutics, Inc.
|
1,938,747 | $2,442,821 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
30,000 | $1,694,700 | |
| 7 | VNDA |
Vanda Pharmaceuticals Inc.
|
241,286 | $1,667,286 | |
| 8 | FATE |
Fate Therapeutics Inc
|
810,000 | $972,000 |
All Filings in RCKT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,368,724 | 2,058,303 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $10,485,408 | 2,987,296 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,428,770 | 2,892,261 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,109,279 | 452,767 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||